🇺🇸 FDA
Pipeline program

Bupivacaine / fentaNYL

PRO16060602

Unknown small_molecule completed

Quick answer

Bupivacaine / fentaNYL for Depression, Postpartum is a Unknown program (small_molecule) at Grace Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Grace Therapeutics
Indication
Depression, Postpartum
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials